BioCentury
ARTICLE | Financial News

Surface Oncology execs join MPM

September 13, 2018 10:51 PM UTC

MPM Capital hired Detlev Biniszkiewicz and Scott Chappel as executive partners. They will be responsible for identifying and evaluating new oncology investment opportunities for MPM, as well as portfolio oversight.

Biniszkiewicz and Chappel are former executives of Surface Oncology Inc. (NASDAQ:SURF), where they guided the immuno-oncology company into the clinic and public market. Surface raised $108 million in an IPO in April...